Matches in Wikidata for { <http://www.wikidata.org/entity/Q92145515> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- Q92145515 description "article scientifique publié en 2019" @default.
- Q92145515 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q92145515 description "im Juli 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92145515 description "scientific article published on 24 July 2019" @default.
- Q92145515 description "wetenschappelijk artikel" @default.
- Q92145515 description "наукова стаття, опублікована 24 липня 2019" @default.
- Q92145515 name "Brentuximab vedotin and anti-PD1 treatment optimize survival in chemo-refractory Hodgkin lymphoma patients: Real-world data" @default.
- Q92145515 name "Brentuximab vedotin and anti-PD1 treatment optimize survival in chemo-refractory Hodgkin lymphoma patients: Real-world data" @default.
- Q92145515 type Item @default.
- Q92145515 label "Brentuximab vedotin and anti-PD1 treatment optimize survival in chemo-refractory Hodgkin lymphoma patients: Real-world data" @default.
- Q92145515 label "Brentuximab vedotin and anti-PD1 treatment optimize survival in chemo-refractory Hodgkin lymphoma patients: Real-world data" @default.
- Q92145515 prefLabel "Brentuximab vedotin and anti-PD1 treatment optimize survival in chemo-refractory Hodgkin lymphoma patients: Real-world data" @default.
- Q92145515 prefLabel "Brentuximab vedotin and anti-PD1 treatment optimize survival in chemo-refractory Hodgkin lymphoma patients: Real-world data" @default.
- Q92145515 P1433 Q92145515-499C3158-B055-409D-8A71-B23CBDEA8301 @default.
- Q92145515 P1476 Q92145515-B632D2EE-CCAD-48B9-AEDC-668F72670F84 @default.
- Q92145515 P2093 Q92145515-04772FC0-1298-498F-84A5-80525F44F6E9 @default.
- Q92145515 P2093 Q92145515-1F43973F-F7D2-4CC3-836F-2B069AD51233 @default.
- Q92145515 P2093 Q92145515-2CC2709F-3BA4-4571-B888-B8FA058FDF97 @default.
- Q92145515 P2093 Q92145515-3CBE8E8E-F2F2-4918-86ED-28F689B972C9 @default.
- Q92145515 P2093 Q92145515-5DCD0A14-52C4-4D9E-8759-FDAEDBDBC47B @default.
- Q92145515 P2093 Q92145515-65952B99-3B9D-4286-BFEA-F53FD9B82A1E @default.
- Q92145515 P2093 Q92145515-8A867076-CCAE-4EE0-B2E9-3085BB0C1BA4 @default.
- Q92145515 P2093 Q92145515-9CF4021C-EE13-4054-A304-8E90F33D80D8 @default.
- Q92145515 P2093 Q92145515-A8BEC02C-B918-49AC-9B5D-6333DFAA90AC @default.
- Q92145515 P2093 Q92145515-AA69EED0-4E39-4FE6-BAC4-3A5F52793E49 @default.
- Q92145515 P2093 Q92145515-BF2CB98A-C0CF-4B9D-8C9E-849315EB8FE3 @default.
- Q92145515 P2093 Q92145515-FBB7E4D6-FEC1-4897-A075-C8AEE562B48F @default.
- Q92145515 P2860 Q92145515-0F4B6CBD-7479-4697-BA87-3A9FE32D0CC8 @default.
- Q92145515 P2860 Q92145515-11A70F4A-BEF3-4370-860D-F14FFC5ECAF8 @default.
- Q92145515 P2860 Q92145515-2CC35D5A-3277-4CD3-83B1-2CEA41EA9F16 @default.
- Q92145515 P2860 Q92145515-4267768A-B032-4185-BAF3-79C98AFF7D0C @default.
- Q92145515 P2860 Q92145515-4F2A011F-5829-4A10-9135-4780BB38FF37 @default.
- Q92145515 P2860 Q92145515-5DE17CD8-A5AF-4FA1-B766-FBDBA5C0D3AB @default.
- Q92145515 P2860 Q92145515-DB63FEE2-1E18-4C20-97A5-DA3C90E95E76 @default.
- Q92145515 P2860 Q92145515-F9797694-0736-457D-8C9B-2F5CE798BF63 @default.
- Q92145515 P304 Q92145515-FE700FA4-783C-4A11-80CD-371AFF672F6F @default.
- Q92145515 P31 Q92145515-67AD53CB-2222-4B52-923A-B367ED13AE73 @default.
- Q92145515 P356 Q92145515-DE9D6EAF-E173-4088-834C-6C441DEE0AD9 @default.
- Q92145515 P433 Q92145515-9614C9AB-1CC6-478A-A434-7ED632D50CB6 @default.
- Q92145515 P478 Q92145515-4F8F050D-337E-4298-8FAE-04FAA1F51C56 @default.
- Q92145515 P50 Q92145515-3824F8E8-7A3A-4982-BEDE-606ACFFAC8E4 @default.
- Q92145515 P50 Q92145515-E230CD9B-F97F-43C7-A892-35F1CA10E0B7 @default.
- Q92145515 P577 Q92145515-ACE38C57-1D1D-4D6B-8605-825D1DE39553 @default.
- Q92145515 P698 Q92145515-0BDAF0EA-3D40-41D5-955B-97450493CCA0 @default.
- Q92145515 P921 Q92145515-AADB7EF8-1FE3-42CF-8CDB-CD265BC0C641 @default.
- Q92145515 P356 HON.2645 @default.
- Q92145515 P698 31339579 @default.
- Q92145515 P1433 Q15762617 @default.
- Q92145515 P1476 "Brentuximab vedotin and anti-PD1 treatment optimize survival in chemo-refractory Hodgkin lymphoma patients: Real-world data" @default.
- Q92145515 P2093 "Anastasia Marvaki" @default.
- Q92145515 P2093 "Antonia Syrigou" @default.
- Q92145515 P2093 "Aristotelis Chatziioannidis" @default.
- Q92145515 P2093 "Despina Mallouri" @default.
- Q92145515 P2093 "I Batsis" @default.
- Q92145515 P2093 "Ioanna Sakellari" @default.
- Q92145515 P2093 "Maria Pilavaki" @default.
- Q92145515 P2093 "Michail Iskas" @default.
- Q92145515 P2093 "Niki Stavroyianni" @default.
- Q92145515 P2093 "Styliani Papaemmanouel" @default.
- Q92145515 P2093 "Varnavas Constantinous" @default.
- Q92145515 P2093 "Zoi Bousiou" @default.
- Q92145515 P2860 Q36356089 @default.
- Q92145515 P2860 Q37279128 @default.
- Q92145515 P2860 Q38386440 @default.
- Q92145515 P2860 Q38906747 @default.
- Q92145515 P2860 Q40386808 @default.
- Q92145515 P2860 Q41437866 @default.
- Q92145515 P2860 Q50271165 @default.
- Q92145515 P2860 Q53510360 @default.
- Q92145515 P304 "490-492" @default.
- Q92145515 P31 Q13442814 @default.
- Q92145515 P356 "10.1002/HON.2645" @default.
- Q92145515 P433 "4" @default.
- Q92145515 P478 "37" @default.
- Q92145515 P50 Q42933010 @default.
- Q92145515 P50 Q54067575 @default.
- Q92145515 P577 "2019-07-24T00:00:00Z" @default.
- Q92145515 P698 "31339579" @default.
- Q92145515 P921 Q209369 @default.